世界の敗血症治療市場2021年-2031年：種類別（重度敗血症、敗血症性ショック、血液浄化敗血症）、治療別、エンドユーザー別

• 英文タイトル：Sepsis Treatment Market (Type: Severe Sepsis, Septic Shock, and Sepsis in Need of Blood Purification; Therapy: Continuous Renal Replacement Therapies [CRRT], Intermittent Hemodialysis, Sustained Low-efficiency Daily Dialysis [SLEDD], and Others; and End User: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

• レポートコード：MRC2106B038 • 出版社/出版日：Transparency Market Research / 2021年4月8日 • レポート形態：英文、PDF、188ページ • 納品方法：Eメール • 産業分類：製薬

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Site Licence	￥1,301,660 (USD8,795)	▷ お問い合わせ
Enterprise Licence	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界の敗血症治療市場について調査し、序論/仮定、調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（重度敗血症、敗血症性ショック、血液浄化敗血症）分析、治療別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを徹底分析したものです。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の敗血症治療市場規模：種類別（重度敗血症、敗血症性ショック、血液浄化敗血症） ・世界の敗血症治療市場規模：治療別 ・世界の敗血症治療市場規模：エンドユーザー別 ・世界の敗血症治療市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Sepsis Treatment Market – Scope of the Report

TMR’s report on the global sepsis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global sepsis treatment market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global sepsis treatment market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global sepsis treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global sepsis treatment market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global sepsis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global sepsis treatment market. The next section of the global sepsis treatment market report highlights the USPs, which include technological advancements, key industry events (mergers, acquisitions, strategic partnerships, etc.), top three players operating in the market space, and COVID-19 pandemic impact on the global sepsis treatment market.

The report delves into the competitive landscape of the global sepsis treatment market. Key players operating in the global sepsis treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global sepsis treatment market report.

Key Questions Answered in Sepsis Treatment Market Report

What are the sales/revenue generated by sepsis manufacturers across all regions during the forecast period?
What are the key trends in the global sepsis market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2031 and which segment will expand at the highest CAGR during the forecast period?
What was the market ranking of different companies operating in the global market in 2020?
Sepsis Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global sepsis treatment market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global sepsis treatment market. It is followed by market introduction, market dynamics, and an overview of the global sepsis treatment market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global sepsis treatment market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global sepsis treatment market in terms of value. The forecast presented here assesses the total revenue generated in the global sepsis treatment market. In order to provide an accurate forecast, we initiated by sizing of the current sepsis treatment market with the help of the parent market.

The report analyzes the global sepsis treatment market in terms of type, therapy, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global sepsis treatment market.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sepsis Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sepsis Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Sepsis Population (admissions as % of population)
5.2. Total Sepsis Hospital Admissions [general ward & other, ICU patients admitted (000)]
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Sepsis Treatment Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
6.3.1. Severe Sepsis
6.3.2. Septic Shock
6.3.3. Sepsis in Need of Blood Purification
6.4. Global Sepsis Treatment Market Attractiveness Analysis, by Type
7. Global Sepsis Treatment Market Analysis and Forecast, by Therapy
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
7.3.1. Continuous Renal Replacement Therapies (CRRT)
7.3.2. Intermittent Hemodialysis
7.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
7.3.4. Others
7.4. Global Sepsis Treatment Market Attractiveness Analysis, by Therapy
8. Global Sepsis Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Centers
8.3.3. Others
8.4. Global Sepsis Treatment Market Attractiveness Analysis, by End-user
9. Global Sepsis Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Sepsis Treatment Market Attractiveness Analysis, by Region
10. North America Sepsis Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type , 2017–2031
10.2.1. Severe Sepsis
10.2.2. Septic Shock
10.2.3. Sepsis in Need of Blood Purification
10.3. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
10.3.1. Continuous Renal Replacement Therapies (CRRT)
10.3.2. Intermittent Hemodialysis
10.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
10.3.4. Others
10.4. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Centers
10.4.3. Others
10.5. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Sepsis Treatment Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Therapy
10.6.3. By End-user
10.6.4. By Country
11. Europe Sepsis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
11.2.1. Severe Sepsis
11.2.2. Septic Shock
11.2.3. Sepsis in Need of Blood Purification
11.3. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
11.3.1. Continuous Renal Replacement Therapies (CRRT)
11.3.2. Intermittent Hemodialysis
11.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
11.3.4. Others
11.4. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Centers
11.4.3. Others
11.5. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Sepsis Treatment Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Therapy
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Sepsis Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
12.2.1. Severe Sepsis
12.2.2. Septic Shock
12.2.3. Sepsis in Need of Blood Purification
12.3. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
12.3.1. Continuous Renal Replacement Therapies (CRRT)
12.3.2. Intermittent Hemodialysis
12.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
12.3.4. Others
12.4. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Centers
12.4.3. Others
12.5. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Sepsis Treatment Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Therapy
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Sepsis Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
13.2.1. Severe Sepsis
13.2.2. Septic Shock
13.2.3. Sepsis in Need of Blood Purification
13.3. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
13.3.1. Continuous Renal Replacement Therapies (CRRT)
13.3.2. Intermittent Hemodialysis
13.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
13.3.4. Others
13.4. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Centers
13.4.3. Others
13.5. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Sepsis Treatment Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Therapy
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Sepsis Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031
14.2.1. Severe Sepsis
14.2.2. Septic Shock
14.2.3. Sepsis in Need of Blood Purification
14.3. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
14.3.1. Continuous Renal Replacement Therapies (CRRT)
14.3.2. Intermittent Hemodialysis
14.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)
14.3.4. Others
14.4. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Centers
14.4.3. Others
14.5. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Sepsis Treatment Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Therapy
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Baxter International, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Fresenius Medical Care AG & Co. KGaA
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Nipro Corporation
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. Asahi Kasei
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. B. Braun Group
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. CytoSorbents Corporation
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Medtronic plc
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. Nikkiso Co., Ltd.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. Medica SPA
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Toray Industries
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
15.2.11. Merck & Co., Inc.
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Financial Overview
15.2.11.3. Product Portfolio
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis

---